Rahul Gosain, MD

Articles by Rahul Gosain, MD

KEYNOTE-789: Chemotherapy With or Without Pembrolizumab for TKI-Resistant Nonsquamous NSCLC

ByRohit Gosain, MD,Rahul Gosain, MD,Charu Aggarwal, MD, MPH

July 7th 2023

Following ASCO 2023, experts in oncology review recent data updates from KEYNOTE-789 on chemotherapy with or without pembrolizumab for TKI-resistant nonsquamous NSCLC.

ADAURA: Overall Survival Analysis of Osimertinib in NSCLC

ByRohit Gosain, MD,Rahul Gosain, MD,Charu Aggarwal, MD, MPH

July 7th 2023

Charu Aggarwal, MD, MPH, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent data updates from the ADAURA trial, an overall survival analysis of osimertinib in non–small cell lung cancer (NSCLC).